The in vitro effects of propofol on tissular oxidative stress in the rat

Anesthesia and Analgesia

Volumn 87, Issue 5, 1998, Pages 1141-1146

  De La Cruz, J P ^a   Sedeno G ^a   Carmona, J A ^a   De La Sanchez Cuesta F ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; PROPOFOL;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANESTHETICS, INTRAVENOUS; ANIMALS; BRAIN CHEMISTRY; GLUTATHIONE; KINETICS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PROPOFOL; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0031753036     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199811000-00031     Document Type: Article

References (16)

1. Musacchio E, Rizzoli V, Blanchi M, et al. Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat. Pharmacol Toxicol 1991;69:75-7.
2. Aarts L, Van Der Hee R, Dekker I, et al. The widely used anesthetic agent propofol can replace alpha-tocopherol as anti-oxidant. FEBS Lett 1995;357(Suppl 1):83-5.
3. Eriksson O, Pollesello P, Saris EN. Inhibition of lipid peroxidation in isolated rat liver mitochondria by the general anesthetic propofol. Biochem Pharmacol 1992;44:391-3.
4. Hans P, Deby C, Deby-Dupont G, et al. Effect of propofol on in vitro lipid peroxidation induced by different free radical generating system: a comparison with vitamin E. Eur J Neurosurg Anesthesiol 1996;8(Suppl 2):154-8.
5. Murphy PG, Myers DS, Webster MJ, et al. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992; 68:613-8.
6. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-63.
7. De La Cruz JP, Carrasco T, Ortega G, Sánchez De La Cuesta F. Inhibition of ferrous-induced lipid peroxidation by pyrimidopyrimidine derivatives in human liver membranes. Lipids 1992; 27:192-4.
8. Bossman HB, Hemsworth BD. Structure and function of nervous tissue. Vol 3. 2nd ed. London: Academic, 1969:1-24.
9. Lowry O, Rosebrough H, Farr A, Randall R. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193: 265-75.
10. Flohe L, Gunzel WA. Assay of glutathione peroxidase. Methods Enzymol 1984;105:114-21.
11. Warholm M, Guthemberg C, Von Bahr C, Mannervik B. Glutathione transferase from human liver. Methods Enzymol 1985; 113:449-503.
12. Cockshott ID. Propofol pharmacokinetics and metabolism: an overview. Postgrad Med J 1985;61(Suppl 3):45-50.
13. Ignarro L, Murad F. Nitric oxide: biochemistry, molecular biology and therapeutic implications. London: Academic, 1995.
14. Warso M, Lands W. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull 1983;39:277-80.
15. De La Cruz JP, Paez MV, Blanco E, et al. Propofol inhibits platelet aggregation in human whole blood [abstract]. Methods Find Exp Clin Pharmacol 1996;18(Suppl B):P106.
16. De La Cruz JP, Carmona JA, Paez MV, et al. Propofol inhibits in vitro platelet aggregation in human whole blood. Anesth Analg 1997;84:919-21.